PyRIDostigmine bromide 60 mg Oral Tablet
RxNorm 903857
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 903857 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pyRIDostigmine bromide 60 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Pyridostigmine bromide 60 mg Oral Tablet
(Atom ID: 12343527)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely pyridostigmine bromide 60 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10316675)
PSNPrescribable
Prescribable Name (PSN):
PyRIDostigmine bromide 60 mg Oral Tablet
(Atom ID: 6368456)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
PyRIDostigmine bromide 60 mg Oral Tablet
(Atom ID: 12815110)
PTPrescribable
Designated preferred name (PT):
Pyridostigmine bromide 60 mg oral tablet
(Atom ID: 10319884)
Patient Education
Pyridostigmine
Pyridostigmine is used to decrease muscle weakness resulting from myasthenia gravis.
[Learn More]
* Please review the disclaimer below.